Early Phase 1 Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People with a BMI (body mass index) under 25, which is generally considered a healthy weight range
- People whose body processes insulin normally, based on blood test results from fasting glucose and insulin levels
- People aged between 18 and 79 years old
- People with blood pressure below 140 (top number) and below 90 mmHg (bottom number)
- People whose weight has stayed roughly the same (within about 5 pounds) over the past 3 months
- People who are willing and able to stop taking vitamin C, vitamin E, or omega-3 fatty acid supplements at least 2 weeks before the trial begins
- People who are willing and able to sign a written consent form agreeing to take part
Who may not be able to join:
- People who have Type 1 or Type 2 diabetes, or whose fasting blood sugar or HbA1c (a measure of average blood sugar) is above certain levels
- People who currently smoke or who have smoked in the past 3 months
- People who have high levels of fats (triglycerides) in their blood, above 250 mg/dL
- People with high blood pressure above 130/80 mmHg
- People with a history of heart disease, such as a heart attack, stroke, heart failure, stent placement, valve problems, or heart muscle disease
- People with a history of vascular (blood vessel) disease, such as bypass surgery or stroke
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Seth W. W Holwerda, PhD, University of Kansas Medical Center
Phone: 9729223230
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Efficacy of Infusion of Ascorbic Acid; Efficacy of Infusion of Ascorbic Acid; Efficacy of Infusion of Ascorbic Acid; Efficacy of Infusion of Ascorbic Acid; Efficacy of Infusion of Ascorbic Acid
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.